{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:12:23Z","timestamp":1758629543534},"reference-count":42,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>As shown with gene expression profiling (GEP), the development and progression of follicular lymphoma (FL) involves complex interactions between neoplastic B cells and the surrounding microenvironment. GEP further reveals that the tumor microenvironment may predict survival in patients with FL and influence the response to therapy and the risk of transformation. Here, we briefly review GEP technology and summarize the role of the tumor microenvironment in FL diagnosis, prognosis, and transformation. Genes expressed by infiltrating T cells and macrophages appear to be the most important predictors of survival, clinical behavior, and outcome. These findings provide a basis for future studies into the pathogenesis and pathophysiology of FL and may ultimately provide guidance in the choice of therapy and the identification of potential therapeutic targets.<\/jats:p>","DOI":"10.1182\/asheducation-2014.1.163","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T18:39:03Z","timestamp":1416854343000},"page":"163-168","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Indolent lymphoma: follicular lymphoma and the microenvironment\u2014insights from gene expression profiling"],"prefix":"10.1182","volume":"2014","author":[{"given":"Lisa M.","family":"Rimsza","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Arizona, Tucson, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melba C.","family":"Jaramillo","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arizona, Tucson, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"4","key":"2019111704151865300_B1","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","article-title":"The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas","volume":"109","author":"Natkunam","year":"2007","journal-title":"Blood"},{"key":"2019111704151865300_B2","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"Swerdlow","year":"2008","edition":"Ed. 4"},{"issue":"17","key":"2019111704151865300_B3","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol"},{"key":"2019111704151865300_B4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.6004\/jnccn.2013.0198","article-title":"Recent advances in the treatment of non-Hodgkin's lymphomas","volume":"11","author":"Abramson","year":"2013","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"2019111704151865300_B5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"issue":"12","key":"2019111704151865300_B6","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V85.12.3671.bloodjournal85123671","article-title":"Prognostic value of cellular proliferation and histologic grade in follicular lymphoma","volume":"85","author":"Martin","year":"1995","journal-title":"Blood"},{"issue":"2","key":"2019111704151865300_B7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3324\/haematol.10682","article-title":"MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes","volume":"92","author":"Naresh","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"2019111704151865300_B8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdp460","article-title":"Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study","volume":"21","author":"Sweetenham","year":"2010","journal-title":"Ann Oncol"},{"issue":"12","key":"2019111704151865300_B9","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1073\/pnas.1137463100","article-title":"Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy","volume":"100","author":"Elenitoba-Johnson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111704151865300_B10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cncr.21500","article-title":"The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma","volume":"108","author":"Goy","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"2019111704151865300_B11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2004-06-2298","article-title":"Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment","volume":"105","author":"Glas","year":"2005","journal-title":"Blood"},{"issue":"21","key":"2019111704151865300_B12","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"2019111704151865300_B13","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1182\/blood-2007-10-115915","article-title":"Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling","volume":"111","author":"Byers","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111704151865300_B14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10428194.2010.531412","article-title":"Gene expression profiling in follicular lymphoma and its implication for clinical practice","volume":"52","author":"Janikova","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"20","key":"2019111704151865300_B15","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1182\/blood-2011-04-345777","article-title":"Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study","volume":"118","author":"Laurent","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111704151865300_B16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/leu.2011.301","article-title":"Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells","volume":"26","author":"Ame-Thomas","year":"2012","journal-title":"Leukemia"},{"issue":"12","key":"2019111704151865300_B17","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2010.223","article-title":"Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis","volume":"24","author":"Pangault","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"2019111704151865300_B18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111704151865300_B19","first-page":"810","article-title":"The tumor microenvironment in follicular lymphoma","volume":"10","author":"Yang","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"issue":"9","key":"2019111704151865300_B20","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"issue":"31","key":"2019111704151865300_B21","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111704151865300_B22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111704151865300_B23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/10428190290026385","article-title":"Th1\/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL)","volume":"43","author":"Jones","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2019111704151865300_B24","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI59806","article-title":"IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma","volume":"122","author":"Yang","year":"2012","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111704151865300_B25","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"issue":"19","key":"2019111704151865300_B26","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-07-0778","article-title":"A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone","volume":"13","author":"Taskinen","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2019111704151865300_B27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2007.12.8298","article-title":"High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial","volume":"26","author":"Canioni","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111704151865300_B28","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1073\/pnas.0437875100","article-title":"Variation in gene expression patterns in follicular lymphoma and the response to rituximab","volume":"100","author":"Bohen","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111704151865300_B29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2141.2006.06255.x","article-title":"Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP","volume":"135","author":"Harjunpaa","year":"2006","journal-title":"Br J Haematol"},{"issue":"32","key":"2019111704151865300_B30","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1200\/JCO.2008.21.1169","article-title":"Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma","volume":"27","author":"Witzig","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111704151865300_B31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/leu.2012.172","article-title":"Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma","volume":"27","author":"Tilly","year":"2013","journal-title":"Leukemia"},{"issue":"20","key":"2019111704151865300_B32","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1158\/1078-0432.CCR-09-1339","article-title":"Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma","volume":"15","author":"Ansell","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"13","key":"2019111704151865300_B33","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111704151865300_B34","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2002-07-2119","article-title":"Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations","volume":"101","author":"Martinez-Climent","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111704151865300_B35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2006.06439.x","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms","volume":"136","author":"Davies","year":"2007","journal-title":"Br J Haematol"},{"issue":"15","key":"2019111704151865300_B36","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood-2009-02-202465","article-title":"A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients","volume":"114","author":"Gentles","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111704151865300_B37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.LAB.0000053913.85892.E9","article-title":"Gene expression profile of serial samples of transformed B-cell lymphomas","volume":"83","author":"de Vos","year":"2003","journal-title":"Lab Invest"},{"issue":"21","key":"2019111704151865300_B38","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2012.44.2137","article-title":"Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation","volume":"31","author":"Kiaii","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111704151865300_B39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1182\/blood-2013-07-512392","article-title":"Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma","volume":"123","author":"Brodtkorb","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2019111704151865300_B40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bjh.12045","article-title":"Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome","volume":"159","author":"Barrans","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111704151865300_B41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jmoldx.2012.01.008","article-title":"Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphoma","volume":"14","author":"Linton","year":"2012","journal-title":"J Mol Diagn"},{"issue":"6","key":"2019111704151865300_B42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.2012.43.4589","article-title":"Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma","volume":"31","author":"Scott","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2014\/1\/163\/1249815\/bep00114000163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2014\/1\/163\/1249815\/bep00114000163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T09:15:37Z","timestamp":1573982137000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2014\/1\/163\/20333\/Indolent-lymphoma-follicular-lymphoma-and-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2014.1.163","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,5]]}}}